Scienjoy Holding Corporation Reports Fiscal Year 2022 Financial Results
Annual Revenues Increased by
Net Income Increased by
Fiscal Year 2022 Operating and Financial Highlights
- Total net revenues increased by
17.0% toRMB1,953.3 million (US ) for the year ended$283.2 million December 31, 2022 fromRMB1,669.4 million for the year endedDecember 31, 2021 . - Gross profit was
RMB283.2 million (US ) for the year ended$41.1 million December 31, 2022 , compared toRMB304.5 million for the year endedDecember 31, 2021 . - Net income increased by
14.8% toRMB195.2 million (US ) for the year ended$28.3 million December 31, 2022 fromRMB170.0 million for the year ended December 31, 2021. - Net income attributable to the Company's shareholders increased by
13.7% toRMB193.3 million (US ) for the year ended$28.0 million December 31, 2022 fromRMB170.0 million for the year endedDecember 31, 2021 . - Adjusted net income attributable to the Company's shareholders was
RMB181.4 million (US ) for the year ended$26.3 million December 31, 2022 , compared toRMB219.0 million for the year endedDecember 31, 2021 . - Total paying users were 702,372 for the year ended
December 31, 2022 , compared to 840,640 for the year endedDecember 31, 2021 . - The Company has 320.2 million registered users by the end of December 31, 2022.
- As of
December 31, 2022 , the Company had cash and cash equivalents ofRMB175.3 million (US ), compared to$25.4 million RMB240.9 million as ofDecember 31, 2021 .
Mr.
Mr.
Fiscal Year 2022 Financial Results
Total net revenues increased by
Cost of revenues increased by
Gross profit decreased by
Total operating expenses decreased by
- Sales and marketing expenses significantly decreased by
55.8% , toRMB2.1 million (US ) for the year ended$0.3 million December 31, 2022 fromRMB4.8 million for the year endedDecember 31, 2021 . This decrease was mainly due to fewer promotional activities. - General and administrative expenses decreased by
6.5% , toRMB61.0 million (US ) for the year ended$8.8 million December 31, 2022 fromRMB65.2 million for the year endedDecember 31, 2021 . The decrease was primarily due to a decrease ofRMB9.5 million in share base compensations, partially offset by more consulting and professional fees due to the expansion of the Company and amortization of intangible asset. - Research and development expenses decreased by
3.6% toRMB67.5 million (US ) for the year ended$9.8 million December 31, 2022 fromRMB70.0 million for the year endedDecember 31, 2021 due to a decrease ofRMB13.9 million in share base compensations, partially offset by higher employee salary and welfare as a result of increased R&D headcounts. - Provision for doubtful accounts was
RMB2.7 million (US ) for the year ended$9.8 million December 31 2022 as compared to a recovery of doubtful accounts ofRMB1.6 million for the year endedDecember 30, 2021 , due to slow collection.
Change in fair value of contingent consideration decreased to
Change in fair value of warrants liability decreased to
Change in fair value of investment in marketable security decreased to
Investment income amounted to
Net income increased by
Net income attributable to the Company's shareholders increased by13.
Adjusted net income attributable to the Company's shareholders decreased to
Basic and diluted net income attributable to the Company's shareholders per ordinary share were both
Adjusted basic and diluted net income attributable to the Company's shareholders per ordinary share were both
As of
Business Outlook
The Company expects its total net revenues to be in the range of
About
Founded in 2011,
Use of Non-GAAP Financial Measures
Adjusted net income is calculated as net income adjusted for change in fair value of contingent consideration, change in fair value of warrant liability and share based compensation. Adjusted basic and diluted net income per ordinary share is non-GAAP net income (loss) attributable to ordinary shareholders divided by weighted average number of ordinary shares used in the calculation of non-GAAP basic and diluted net income per ordinary share. The non-GAAP financial measures are presented to enhance investors' overall understanding of the Company's financial performance and should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with
For more information on these non-GAAP financial measures, please see the table captioned "Reconciliations of Non-GAAP Results" near the end of this release.
Exchange Rate Information
This announcement contains translations of certain RMB amounts into
Safe Harbor Statement
Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are: the ability to manage growth; ability to identify and integrate other future acquisitions; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in general economic and business conditions; costs or other factors adversely affecting our profitability; litigation involving patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including those more fully described in the Company's filings with the
Investor Relations Contact
Chief Financial Officer
+86-10-64428188
ir@scienjoy.com
Ascent Investor Relations
+1 (917) 609-0333
tina.xiao@ascent-ir.com
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||||||
(All amounts in thousands, except share and per share data or otherwise stated) | ||||||||||||
As of | ||||||||||||
2021 | 2022 | 2022 | ||||||||||
RMB | RMB | USD | ||||||||||
ASSETS | ||||||||||||
Current assets | ||||||||||||
Cash and cash equivalents | 240,947 | 175,292 | 25,415 | |||||||||
Accounts receivable, net | 206,307 | 316,657 | 45,911 | |||||||||
Prepaid expenses and other current assets | 165,409 | 115,170 | 16,699 | |||||||||
Amounts due from related parties | 1,059 | 1,115 | 162 | |||||||||
Investment in marketable security | 38,789 | 40,548 | 5,879 | |||||||||
Total current assets | 652,511 | 648,782 | 94,066 | |||||||||
Property and equipment, net | 1,674 | 2,735 | 397 | |||||||||
Intangible assets, net | 235,870 | 419,055 | 60,757 | |||||||||
| 92,069 | 172,781 | 25,051 | |||||||||
Long term investment | 101,727 | 234,176 | 33,952 | |||||||||
Long term deposits and other assets | 1,152 | 953 | 138 | |||||||||
Right-of-use assets | - | 19,209 | 2,785 | |||||||||
Deferred tax assets | 4,352 | 4,337 | 629 | |||||||||
Total non-current assets | 436,844 | 853,246 | 123,709 | |||||||||
TOTAL ASSETS | 1,089,355 | 1,502,028 | 217,775 | |||||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||
Current liabilities | ||||||||||||
Bank loan | - | 5,000 | 725 | |||||||||
Accounts payable | 85,801 | 116,251 | 16,855 | |||||||||
Accrued salary and employee benefits | 24,533 | 12,428 | 1,802 | |||||||||
Accrued expenses and other current liabilities | 16,181 | 13,264 | 1,923 | |||||||||
Current portion of contingent consideration – earn-out liability | 10,638 | 4,336 | 629 | |||||||||
Warrant liabilities | 10,324 | 166 | 24 | |||||||||
Income tax payable | 8,282 | 13,531 | 1,962 | |||||||||
Lease liabilities-current | - | 7,174 | 1,040 | |||||||||
Deferred revenue | 65,405 | 93,383 | 13,539 | |||||||||
Total current liabilities | 221,164 | 265,533 | 38,499 | |||||||||
Non-current liabilities | ||||||||||||
Deferred tax liabilities | 58,746 | 61,236 | 8,878 | |||||||||
Lease liabilities-non-current | - | 12,773 | 1,852 | |||||||||
Total non-current liabilities | 58,746 | 74,009 | 10,730 | |||||||||
TOTAL LIABILITIES | 279,910 | 339,542 | 49,229 | |||||||||
Commitments and contingencies Shareholders' equity* | ||||||||||||
Ordinary share, no par value, unlimited Class A ordinary shares | ||||||||||||
Class A ordinary shares | 140,196 | 396,880 | 57,542 | |||||||||
Class B ordinary shares | 13,041 | 23,896 | 3,465 | |||||||||
Shares to be issued | 128,119 | 33,923 | 4,918 | |||||||||
Treasury stocks | - | (16,482) | (2,390) | |||||||||
Statutory reserves | 31,775 | 39,208 | 5,685 | |||||||||
Retained earnings | 479,199 | 665,099 | 96,430 | |||||||||
Accumulated other comprehensive income | 17,115 | 18,070 | 2,622 | |||||||||
Total shareholders' equity | 809,445 | 1,160,594 | 168,272 | |||||||||
Noncontrolling interest | - | 1,892 | 274 | |||||||||
Total equity | 809,445 | 1,162,486 | 168,546 | |||||||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | 1,089,355 | 1,502,028 | 217,775 |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE | ||||||||||||||
(All amounts in thousands, except share and per share data or otherwise stated) | ||||||||||||||
For the years ended | ||||||||||||||
2021 | 2022 | 2022 | ||||||||||||
RMB | RMB | USD | ||||||||||||
Live streaming - consumable virtual items | 1,617,056 | 1,886,179 | 273,470 | |||||||||||
Live streaming - time based virtual item revenue | 32,905 | 27,683 | 4,014 | |||||||||||
Technical services and others | 19,397 | 39,395 | 5,712 | |||||||||||
Total revenue | 1,669,358 | 1,953,257 | 283,196 | |||||||||||
Cost of revenues | (1,364,902) | (1,670,068) | (242,137) | |||||||||||
Gross profit | 304,456 | 283,189 | 41,059 | |||||||||||
Sales and marketing expenses | (4,807) | (2,127) | (308) | |||||||||||
General and administrative expenses | (65,233) | (61,005) | (8,845) | |||||||||||
Research and development expenses | (70,039) | (67,538) | (9,792) | |||||||||||
(Provision for) recovery of doubtful accounts | 1,592 | (2,739) | (397) | |||||||||||
Income from operations | 165,969 | 149,780 | 21,717 | |||||||||||
Interest income, net | 3,962 | 2,506 | 363 | |||||||||||
Other income (loss), net | (90) | 11,443 | 1,659 | |||||||||||
Foreign exchange gain (loss), net | 105 | (1,493) | (216) | |||||||||||
Change in fair value of investment | 25,831 | 1,760 | 255 | |||||||||||
Change in fair value of warrant liabilities | 16,421 | 10,776 | 1,562 | |||||||||||
Investments income (loss) | (2,998) | 25,449 | 3,690 | |||||||||||
Change in fair value of contingent consideration | (33,584) | 13,071 | 1,895 | |||||||||||
Income before income taxes | 175,616 | 213,292 | 30,925 | |||||||||||
Income tax expense | (5,604) | (18,067) | (2,619) | |||||||||||
Net income | 170,012 | 195,225 | 28,306 | |||||||||||
Less: net income attributable to | - | 1,892 | 274 | |||||||||||
Net income attributable to the Company's | 170,012 | 193,333 | 28,032 | |||||||||||
Other comprehensive income: | ||||||||||||||
Other comprehensive income - foreign | 2,313 | 955 | 138 | |||||||||||
Comprehensive income | 172,325 | 196,180 | 28,444 | |||||||||||
Less: comprehensive income attributable to | - | 1,892 | 274 | |||||||||||
Comprehensive income attributable to the | 172,325 | 194,288 | 28,170 | |||||||||||
Weighted average number of shares * | ||||||||||||||
Basic | 30,842,183 | 39,263,147 | 39,263,147 | |||||||||||
Diluted | 30,842,183 | 39,263,147 | 39,263,147 | |||||||||||
Earnings per share | ||||||||||||||
Basic | 5.51 | 4.92 | 0.71 | |||||||||||
Diluted | 5.51 | 4.92 | 0.71 |
Reconciliations of Non-GAAP Results | ||||||||||||
(All amounts in thousands, except share and per share data or otherwise stated) | ||||||||||||
For the years ended | ||||||||||||
2021 | 2022 | 2022 | ||||||||||
RMB | RMB | US$ | ||||||||||
Net income attributable to the Company's | 170,012 | 193,333 | 28,032 | |||||||||
Less: | ||||||||||||
Change in fair value of contingent consideration | (33,584) | 13,071 | 1,895 | |||||||||
Change in fair value of warrants liability | 16,421 | 10,776 | 1,562 | |||||||||
Share based compensation | (31,857) | (11,954) | (1,733) | |||||||||
Adjusted net income attributable to the | 219,032 | 181,440 | 26,308 | |||||||||
Adjusted net income per ordinary share | ||||||||||||
Basic | 7.10 | 4.62 | 0.67 | |||||||||
Diluted | 7.10 | 4.62 | 0.67 |
"Adjusted net income attributable to the Company's shareholders" is defined as net income attributable to the Company's shareholders excluding change in fair value of contingent consideration, change in fair value of warrant liability and share based compensation. For more information, refer to "Use of Non-GAAP Financial Measures" and "Reconciliations of Non-GAAP Results" at the end of this press release.
View original content:https://www.prnewswire.com/news-releases/scienjoy-holding-corporation-reports-fiscal-year-2022-financial-results-301810648.html
SOURCE